Roche: Have Abandoned Some Trials Due to U.S. Drug Pricing Plans

By Reuters

FRANKFURT (Reuters) -Roche said it had abandoned certain drug development projects or acquisitions under consideration because of planned price cuts in best-selling prescription medicines in the United States...

Read full story